Search results
Why Is Verastem (VSTM) Stock Down 62% Today?
InvestorPlace· 18 hours agoVerastem (NASDAQ:VSTM) stock is falling hard on Friday following the release of new clinical trial data for its metastatic pancreatic cancer treatment....
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
Zacks via Yahoo Finance· 16 hours agoVerastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga via Yahoo Finance· 17 hours agoThursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results...
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 16 hours agoThe stock plunge comes after Verastem (Nasdaq: VSTM) announced it planned to apply for accelerated...
Verastem opened 70% down on Friday: what happened? | Invezz
Invezz· 17 hours agoVerastem Inc (NASDAQ: VSTM) opened nearly 70% down this morning even though the pharmaceutical firm reported positive interim data for its combination therapy as a treatment ...
Crude Oil Rises 1%; Verastem Shares Slide - Verastem (NASDAQ:VSTM)
Benzinga· 13 hours agoOutdoor Corporation DECK shares were also up, gaining 13% to $1,026.72 after the company reported...
Verastem's stock takes a hit after sharing updated filing plans in ovarian cancer
Endpoints News· 17 hours agoThe company’s shares $VSTM were trading up over 50% after hours based on Thursday’s promising early results from its targeted drug combination in pancreatic cancer, a devastating ...
Verastem stock target cut on trial results, keeps Buy rating By Investing.com
Investing.com· 15 hours agoOn Friday, Verastem (NASDAQ:VSTM) shares plummeted approximately 63% following an update on clinical...
Verastem (NASDAQ:VSTM) Stock Price Crosses Above 200-Day Moving Average of $10.14
ETF DAILY NEWS· 4 days agoVerastem, Inc. (NASDAQ:VSTM – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $10.14 and traded ...
BTIG Research gives a Buy recommendation for Verastem Inc
Knox Daily· 3 days agoA number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Mizuho also remained covering ...
